Drug Coated PTA Balloon Catheter

OVERVIEW

Drug Coated PTA Balloon Catheter

ENSURE EFFECTIVE DRUG DELIVERY OF A SAFE THERAPEUTIC DOSAGE

The Drug-Coated PTA Balloon Catheter, a versatile and effective PAD treatment option, features unique PTA Coating Technology and is available on the 0.014”, 0.018” and 0.035” balloon catheter platforms.

Product Features

Drug Coated PTA Balloon Catheters

A carrrier or an excipient is not always necessary

Coating Technology

01

The DCB drug dose of paclitaxel is 3μg/mm².

02

UltraFree™ Coating Technology effectively controls paclitaxel crystallization process, resulting in a uniform and stable microcrystal drug coating.

03

Particle size distribution test results show that 75% of the particles related are in 5-10μm range.

04

The integrated UltraFree™ coating prevents the early drug flaking during the procedure preparation and the device tracking.

05

UltraFree™ Coating quickly disintegrates into microcrystalline particles at the lesion site and allows rapid drug transfer to the arterial wall.

06

The effective drug tissue concentration at the lesion site lasts for more than 90 days.

More options with the clinically proven platforms

The DCB is based upon the PTA balloons platform and features

Low entry profile and excellent crossability

Advanced pushability

Long balloon lengths up to 220mm

ORDER INFORMATION

INDICATIONS

Drug Coated PTA Balloon Catheter

The ZENFLUXION™ Drug-coated PTA Balloon Catheters are indicated for Percutaneous Transluminal Angioplasty (PTA) of stenosis or occlusion lesions in iliac, femoral or popliteal arteries.

Zylox-Tonbridge Medical highlights the corporate social responsibility and mission, and boosts the innovation and technological development by taking active part in the combination of scientific innovation with medical engineering. Besides, we keep launching the professional teaching activities to the practitioners in the medical field, regulating the employees and partners to observe the high-level compliance policies and codes of ethics, performing the corporate social responsibilities, and abiding by the commitment to the shareholders and all other stakeholders.